It isn’t always easy to know what to believe when it comes to cancer. In part 2 of a Daily Maverick and Spotlight special series on cancer, Biénne Huisman asks whether cancer cases are on the increase in South Africa, and why. On the way, she visits academic corridors and a Limpopo citrus orchard, all while trying to make sense of the available data.
Biénne Huisman meets South Africa’s recently appointed Deputy Director-General for HIV, AIDS, TB and sexually transmitted infections, discussing the latest HIV prevention medicines, her career turning points, and bedtime reading.
South Africa has the world’s largest population of people living with HIV, which both heightens the risk of anal cancers and their severity. However, neither the collection of data nor the efforts for prevention and screening are in line with the likely impact. Experts say significant change is needed, reports Elna Schütz.
A decade into South Africa’s HPV vaccination programme, the health department is switching from a two-dose to a single dose vaccine regimen and girls in private schools are set to start receiving government subsidised jabs. The vaccine provided, GlaxoSmithKline’s Cervarix, will remain the same. The move is backed by evidence showing one-dose regimens provide similar protection against HPV infection as multi-dose regimens. Catherine Tomlinson reports.
The World Health Organization in February this year said that an estimated 1.1 million new cancer cases are being reported in Africa each year with around 700 000 deaths from cancer. A recent report provides important new data on cancer in South Africa, but the picture remains incomplete. Ufrieda Ho reports.
South Africa’s HPV vaccination programme has by all accounts been a resounding success over the last decade, likely helping to prevent many cases of cervical cancer. But the programme has suffered major setbacks due to COVID-19-related disruptions and in addition to getting it back on track, some argue vaccine eligibility should be expanded to include boys as well as older girls and women newly infected with HIV. Amy Green takes stock of the country’s HPV vaccination efforts.
As a rebellious teenager growing up in the British town of Harpenden, Professor Helen Rees would sneak out to attend anti-apartheid talks. Today, she is a renowned scientist and chair of South Africa’s medicines regulator. Biénne Huisman chatted to Rees about her career, prioritising women’s reproductive health, and her role at the South African Health Products Regulatory Authority.
Being a midwife is not a career for her, says Sebabatso Tsosane – it’s a calling. Refilwe Mochoari spoke to Tsosane – a midwife, lecturer, and founder of the Free State-based organisation Black Women Arise – about her passion to empower women with knowledge about their sexual and reproductive health as part of Spotlight’s Women in Health series.
An innovative new technology that allows women to collect their own samples for HPV testing, rather than having the sample taken by a healthcare worker, was recently tested in the Eastern Cape. Elri Voigt spoke to local experts about the study and what such a self-collected test might mean for cervical cancer detection in South Africa.
Professor Lynette Denny of the University of Cape Town recently received the Order of the Baobab, the country’s highest accolade for citizen excellence. Bienne Huisman spoke to her about her ground-breaking research in cervical cancer prevention, her own ongoing struggle with cancer, and the enrichment she has found in being of service.
In 2014, South Africa launched an HPV vaccination campaign targeting 9-year-old public school learners in Grade 4. It involves delivering two doses of vaccine six months apart. Laura Owings asks how the campaign is going and what recent real-world HPV vaccine effectiveness data from the United Kingdom might mean for South Africa.
Four years ago, the virtual collapse of cancer services in KwaZulu-Natal saw some desperate patients move to Gauteng for care. Now, a new crisis is again prompting those who can, to relocate for treatment. Laura Lopez Gonzalez reports.
